CRISPR Therapeutics (CRSP) - Analyst Comments

CRISPR Therapeutics (CRSP) – Analyst Comments

Feb 7, 2024 02:28 PM CRISPR Therapeutics (CRSP) PT Lowered to $120 at Truist Securities
Dec 11, 2023 06:19 AM TD Cowen Downgrades CRISPR Therapeutics (CRSP) to Underperform on lack of confidence in Casgevy launch
Oct 24, 2023 05:06 AM
Sep 26, 2023 04:03 PM
Aug 17, 2023 02:27 PM
Apr 13, 2023 06:33 AM
Sep 29, 2022 09:19 AM
Aug 9, 2022 05:34 AM
Jul 14, 2022 07:23 AM
Jun 23, 2022 08:25 AM
Jun 22, 2022 06:10 AM
Jun 16, 2022 04:14 PM
May 10, 2022 05:43 AM
Apr 8, 2022 04:05 PM
Mar 10, 2022 06:19 AM
Feb 16, 2022 12:38 PM
Feb 16, 2022 06:23 AM
Feb 16, 2022 03:13 AM
Feb 14, 2022 06:21 AM
Dec 20, 2021 08:57 AM
Dec 6, 2021 04:07 PM
Nov 4, 2021 07:16 AM
Oct 13, 2021 06:33 AM
Oct 13, 2021 06:22 AM
Aug 2, 2021 07:27 AM
Jul 30, 2021 07:53 AM
Jun 30, 2021 06:27 AM
Jun 14, 2021 02:54 AM
Apr 21, 2021 09:09 AM
Apr 20, 2021 11:53 AM
Dec 10, 2020 08:07 AM
Dec 10, 2020 07:30 AM
Dec 7, 2020 06:05 AM
Jul 29, 2020 08:37 AM
Jul 28, 2020 09:26 AM
Jun 29, 2020 08:59 AM
Jun 23, 2020 08:43 AM
Jun 22, 2020 04:54 PM
Mar 4, 2020 04:17 PM
Dec 31, 2019 07:03 AM
Nov 12, 2019 07:18 AM
Oct 28, 2019 10:25 AM
Oct 28, 2019 10:16 AM
Jun 27, 2019 07:08 AM
Feb 8, 2019 07:00 AM
Feb 7, 2019 12:58 PM
Jan 28, 2019 05:41 AM
Jan 22, 2019 09:18 AM
Jan 3, 2019 10:34 AM
Nov 30, 2018 06:55 AM